Latest News
Via The Motley Fool · April 30, 2025
Industrial equipment and engineered products manufacturer Albany (NYSE:AIN) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 7.8% year on year to $288.8 million. The company’s full-year revenue guidance of $1.22 billion at the midpoint came in 1.4% below analysts’ estimates. Its non-GAAP profit of $0.73 per share was 17.4% above analysts’ consensus estimates.
Via StockStory · April 30, 2025
Bob Lang gives technical analysis of the stock chart for FTNT.
Via Talk Markets · April 30, 2025
Bedding manufacturer and retailer Sleep Number (NASDAQ:SNBR) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 16.4% year on year to $393.3 million. Its GAAP loss of $0.38 per share was significantly below analysts’ consensus estimates.
Via StockStory · April 30, 2025
Online casino and sports betting company Rush Street Interactive (NYSE:RSI) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 20.7% year on year to $262.4 million. On the other hand, the company’s full-year revenue guidance of $1.05 billion at the midpoint came in 0.8% below analysts’ estimates. Its non-GAAP profit of $0.09 per share was 47.7% above analysts’ consensus estimates.
Via StockStory · April 30, 2025
Heavy equipment distributor Custom Truck One Source (NYSE:CTOS) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 2.7% year on year to $422.2 million. On the other hand, the company’s full-year revenue guidance of $2.02 billion at the midpoint came in 2.1% above analysts’ estimates. Its GAAP loss of $0.08 per share was 36% below analysts’ consensus estimates.
Via StockStory · April 30, 2025
Medical tech company CONMED (NYSE:CNMD) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.9% year on year to $321.3 million. The company expects the full year’s revenue to be around $1.36 billion, close to analysts’ estimates. Its non-GAAP profit of $0.95 per share was 17.1% above analysts’ consensus estimates.
Via StockStory · April 30, 2025
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around $1 billion, close to analysts’ estimates. Its GAAP loss of $1.97 per share was significantly below analysts’ consensus estimates.
Via StockStory · April 30, 2025
IT solutions provider Connection (NASDAQ:CNXN) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 10.9% year on year to $701 million. Its non-GAAP profit of $0.60 per share was 44.6% above analysts’ consensus estimates.
Via StockStory · April 30, 2025
PCB manufacturing company TTM Technologies (NASDAQ:TTMI) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 13.8% year on year to $648.7 million. On top of that, next quarter’s revenue guidance ($670 million at the midpoint) was surprisingly good and 4% above what analysts were expecting. Its non-GAAP profit of $0.50 per share was 26.6% above analysts’ consensus estimates.
Via StockStory · April 30, 2025
Online marketplace eBay (NASDAQ:EBAY) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 1.1% year on year to $2.59 billion. Guidance for next quarter’s revenue was better than expected at $2.63 billion at the midpoint, 0.9% above analysts’ estimates. Its non-GAAP profit of $1.38 per share was 3.2% above analysts’ consensus estimates.
Via StockStory · April 30, 2025
Commercial vehicle retailer Rush Enterprises (NASDAQ:RUSH.A) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 1.1% year on year to $1.85 billion. Its GAAP profit of $0.73 per share was 1.4% above analysts’ consensus estimates.
Via StockStory · April 30, 2025
Manufacturing equipment and systems provider Advanced Energy (NASDAQ:AEIS) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 23.6% year on year to $404.6 million. On top of that, next quarter’s revenue guidance ($420 million at the midpoint) was surprisingly good and 5.4% above what analysts were expecting. Its non-GAAP profit of $1.23 per share was 16.1% above analysts’ consensus estimates.
Via StockStory · April 30, 2025
One more quarter of contraction and we’re in a recession.
Via Talk Markets · April 30, 2025
Electrical construction and infrastructure services provider MYR Group (NASDAQ:MYRG) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 2.2% year on year to $833.6 million. Its GAAP profit of $1.45 per share was 23.5% above analysts’ consensus estimates.
Via StockStory · April 30, 2025
Via The Motley Fool · April 30, 2025
Via Benzinga · April 30, 2025
American firearm manufacturing company Ruger (NYSE:RGR) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $135.7 million. Its GAAP profit of $0.46 per share increased from $0.40 in the same quarter last year.
Via StockStory · April 30, 2025
Hospitality and casino entertainment company MGM Resorts (NYSE:MGM) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 2.4% year on year to $4.28 billion. Its non-GAAP profit of $0.69 per share was 51.5% above analysts’ consensus estimates.
Via StockStory · April 30, 2025
Dental technology company Align Technology (NASDAQ:ALGN) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.8% year on year to $979.3 million. The company expects next quarter’s revenue to be around $1.06 billion, coming in 0.8% above analysts’ estimates. Its non-GAAP profit of $2.13 per share was 7.1% above analysts’ consensus estimates.
Via StockStory · April 30, 2025
Health and wellness products company Herbalife (NYSE:HLF) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.4% year on year to $1.22 billion. Next quarter’s revenue guidance of $1.26 billion underwhelmed, coming in 0.6% below analysts’ estimates. Its non-GAAP profit of $0.59 per share was 44.9% above analysts’ consensus estimates.
Via StockStory · April 30, 2025